60 related articles for article (PubMed ID: 28099724)
1. Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
Vodicka EL; Babigumira JB; Mann MR; Kosgei RJ; Lee F; Mugo NR; Okech TC; Sakr SR; Garrison LP; Chung MH
Int J Gynaecol Obstet; 2017 Feb; 136(2):220-228. PubMed ID: 28099724
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study of the prevalence, barriers, and facilitators of cervical cancer screening in family planning clinics in Mombasa County, Kenya.
Eastment MC; Wanje G; Richardson BA; Mwaringa E; Patta S; Sherr K; Barnabas RV; Mandaliya K; Jaoko W; McClelland RS
BMC Health Serv Res; 2022 Dec; 22(1):1577. PubMed ID: 36564740
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya.
Orang'o EO; Wachira J; Asirwa FC; Busakhala N; Naanyu V; Kisuya J; Otieno G; Keter A; Mwangi A; Inui T
PLoS One; 2016; 11(6):e0157217. PubMed ID: 27310005
[TBL] [Abstract][Full Text] [Related]
4. Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya.
Rosser JI; Njoroge B; Huchko MJ
Int J Gynaecol Obstet; 2015 Mar; 128(3):211-5. PubMed ID: 25467908
[TBL] [Abstract][Full Text] [Related]
5. Cost of integrating assisted partner services in HIV testing services in Kisumu and Homa Bay counties, Kenya: a microcosting study.
Wamuti B; Sharma M; Kariithi E; Lagat H; Otieno G; Bosire R; Masyuko S; Mugambi M; Weiner BJ; Katz DA; Farquhar C; Levin C
BMC Health Serv Res; 2022 Jan; 22(1):69. PubMed ID: 35031037
[TBL] [Abstract][Full Text] [Related]
6. Integrating HIV testing into cervical cancer screening in Tanzania: an analysis of routine service delivery statistics.
Plotkin M; Besana GV; Yuma S; Kim YM; Kulindwa Y; Kabole F; Lu E; Giattas MR
BMC Womens Health; 2014 Sep; 14():120. PubMed ID: 25271025
[TBL] [Abstract][Full Text] [Related]
7. The cost of implementing the Systems Analysis and Improvement Approach for a cluster randomized trial integrating HIV testing into family planning services in Mombasa County, Kenya.
Thomas D; Wanje G; Eastment MC; McClelland RS; Mwaringa E; Patta S; Jaoko W; Kinuthia J; Abubakar A; Sherr K; Barnabas RV
BMC Health Serv Res; 2022 Dec; 22(1):1480. PubMed ID: 36471311
[TBL] [Abstract][Full Text] [Related]
8. Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
Mungo C; Orang'o O; Ofner S; Musick B; Yiannoutsos C; Cohen CR; Brown D; Wools-Kaloustian K; Semeere A
JCO Glob Oncol; 2024 Feb; 10():e2300311. PubMed ID: 38359369
[TBL] [Abstract][Full Text] [Related]
9. Improving cervical cancer screening rates in an urban HIV clinic.
Cross SL; Suharwardy SH; Bodavula P; Schechtman K; Overton ET; Onen NF; Lane MA
AIDS Care; 2014; 26(9):1186-93. PubMed ID: 24625234
[TBL] [Abstract][Full Text] [Related]
10. Results of a cluster randomized trial testing the Systems Analysis and Improvement Approach to increase cervical cancer screening in family planning clinics in Mombasa County, Kenya.
Eastment MC; Wanje G; Richardson BA; Mwaringa E; Patta S; Sherr K; Barnabas RV; Mandaliya K; Jaoko W; Mcclelland RS
Implement Sci; 2023 Nov; 18(1):66. PubMed ID: 38012647
[TBL] [Abstract][Full Text] [Related]
11. Cost analysis of implementing HIV drug resistance testing in Kenya: a case study of a service delivery site at a tertiary level hospital in Kenya.
Gachogo RW; Mwai DN; Onyambu FG
F1000Res; 2020; 9():793. PubMed ID: 32983418
[No Abstract] [Full Text] [Related]
12. HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?
Hyle EP; Naidoo K; Su AE; El-Sadr WM; Freedberg KA
J Acquir Immune Defic Syndr; 2014 Sep; 67 Suppl 1(0 1):S87-95. PubMed ID: 25117965
[TBL] [Abstract][Full Text] [Related]
13. Perception of Cervical Cancer Patients on their Financial Challenges in Western Kenya.
Owenga JA; Nyambedha EO
BMC Health Serv Res; 2018 Apr; 18(1):261. PubMed ID: 29631577
[TBL] [Abstract][Full Text] [Related]
14. Health technology assessment on cervical cancer screening, 2000-2014.
Lahue BJ; Baginska E; Li SS; Parisi M
Int J Technol Assess Health Care; 2015 Jan; 31(3):171-80. PubMed ID: 26179276
[TBL] [Abstract][Full Text] [Related]
15. A time-motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland.
Palma AM; Rabkin M; Simelane S; Gachuhi AB; McNairy ML; Nuwagaba-Biribonwoha H; Bongomin P; Okello VN; Bitchong RA; El-Sadr WM
J Int AIDS Soc; 2018 Mar; 21(3):e25099. PubMed ID: 29577617
[TBL] [Abstract][Full Text] [Related]
16. Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study.
Gilmore EV; Russell LB; Harvie HS; Schreiber CA
Contraception; 2024 Apr; ():110468. PubMed ID: 38648923
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya.
Zimmermann MR; Vodicka E; Babigumira JB; Okech T; Mugo N; Sakr S; Garrison LP; Chung MH
Cost Eff Resour Alloc; 2017; 15():13. PubMed ID: 28725164
[TBL] [Abstract][Full Text] [Related]
18. Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya.
Vodicka EL; Chung MH; Zimmermann MR; Kosgei RJ; Lee F; Mugo NR; Okech TC; Sakr SR; Stergachis A; Garrison LP; Babigumira JB
PLoS One; 2019; 14(6):e0217331. PubMed ID: 31170193
[TBL] [Abstract][Full Text] [Related]
19. HPV-based cervical cancer screening in low-resource settings: Maximizing the efficiency of community-based strategies in rural Kenya.
Huchko MJ; Olwanda E; Choi Y; Kahn JG
Int J Gynaecol Obstet; 2020 Mar; 148(3):386-391. PubMed ID: 31849036
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
